Processa Pharma Q3 2024 GAAP EPS $(1.03) Misses $(1.00) Estimate

BenzingaOct 31 05:00

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results

GlobeNewswireOct 31 04:15

Processa Pharmaceuticals | 10-Q: Quarterly report

SECOct 31 04:07 · Announcements

Processa Pharmaceuticals Price Target Maintained With a $6.00/Share by HC Wainwright & Co.

Dow JonesOct 3 19:53 · Ratings

Processa Pharma Analyst Ratings

BenzingaOct 3 19:41 · Ratings

H.C. Wainwright Maintains Processa Pharmaceuticals(PCSA.US) With Buy Rating, Maintains Target Price $6

Futu NewsOct 3 18:35 · Ratings